Total Payments
$2,307
2024 Payments
$79.39
Companies
24
Transactions
136
Medicare Patients
1,529
Medicare Billing
$144,272
Payment Breakdown by Category
Food & Beverage$2,307 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,307 | 136 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $482.46 | 30 | $0 (2024) |
| Novo Nordisk Inc | $312.14 | 25 | $0 (2023) |
| Lilly USA, LLC | $186.91 | 11 | $0 (2021) |
| PFIZER INC. | $183.69 | 10 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $162.99 | 9 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $120.76 | 8 | $0 (2020) |
| GlaxoSmithKline, LLC. | $119.59 | 5 | $0 (2024) |
| Respiratory Technologies, Inc. | $94.54 | 2 | $0 (2017) |
| Allergan, Inc. | $87.18 | 4 | $0 (2020) |
| Dexcom, Inc. | $65.04 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.39 | 4 | GlaxoSmithKline, LLC. ($52.49) |
| 2023 | $90.98 | 5 | GlaxoSmithKline, LLC. ($32.09) |
| 2022 | $153.71 | 17 | Novo Nordisk Inc ($124.50) |
| 2021 | $109.59 | 6 | Abbott Laboratories ($31.07) |
| 2020 | $620.70 | 35 | AstraZeneca Pharmaceuticals LP ($138.41) |
| 2019 | $451.30 | 25 | AstraZeneca Pharmaceuticals LP ($147.96) |
| 2018 | $374.74 | 21 | AstraZeneca Pharmaceuticals LP ($113.27) |
| 2017 | $426.88 | 23 | Respiratory Technologies, Inc. ($94.54) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Diabetes | ||||||
| 10/17/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 09/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Diabetes | ||||||
| 11/04/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: VACCINES | ||||||
| 10/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: Diabetes | ||||||
| 10/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.33 | General |
| Category: Diabetes | ||||||
| 09/15/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: Diabetes | ||||||
| 08/22/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Diabetes | ||||||
| 08/22/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: Diabetes | ||||||
| 07/21/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: Diabetes | ||||||
| 05/23/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 05/23/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: Diabetes | ||||||
| 05/12/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Diabetes Care | ||||||
| 04/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Diabetes | ||||||
| 03/28/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Diabetes | ||||||
| 03/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Diabetes | ||||||
| 03/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Diabetes | ||||||
| 02/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 413 | 484 | $78,799 | $31,325 |
| 2022 | 10 | 396 | 552 | $72,405 | $30,766 |
| 2021 | 8 | 338 | 554 | $90,679 | $39,206 |
| 2020 | 9 | 382 | 658 | $76,517 | $42,976 |
Total Patients
1,529
Total Services
2,248
Medicare Billing
$144,272
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 119 | $28,385 | $10,326 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 82 | 82 | $21,204 | $10,200 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 96 | $15,045 | $4,709 | 31.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 27 | $2,430 | $1,942 | 79.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 18 | $3,290 | $1,072 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $1,921 | $904.68 | 47.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 50 | 50 | $2,111 | $901.00 | 42.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 24 | $2,488 | $743.07 | 29.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 27 | 38 | $1,925 | $526.93 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 212 | $43,460 | $17,242 | 39.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 67 | $9,715 | $4,144 | 42.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 60 | 74 | $6,660 | $2,591 | 38.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $1,704 | $1,645 | 96.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 45 | 76 | $3,040 | $1,299 | 42.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $3,382 | $1,185 | 35.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 36 | $1,272 | $1,087 | 85.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 16 | $2,320 | $946.10 | 40.8% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 11 | 11 | $495.00 | $442.66 | 89.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 17 | $357.00 | $183.87 | 51.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 345 | $69,703 | $29,226 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 69 | $9,906 | $4,491 | 45.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 18 | 21 | $4,117 | $2,011 | 48.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 18 | 18 | $2,532 | $1,116 | 44.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 13 | 13 | $1,300 | $863.59 | 66.4% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 38 | 50 | $2,000 | $775.20 | 38.8% |
About Dr. Ramendeep Singh, M.D
Dr. Ramendeep Singh, M.D is a Family Medicine healthcare provider based in Barstow, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2013. The National Provider Identifier (NPI) number assigned to this provider is 1255777421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramendeep Singh, M.D has received a total of $2,307 in payments from pharmaceutical and medical device companies, with $79.39 received in 2024. These payments were reported across 136 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,307).
As a Medicare-enrolled provider, Singh has provided services to 1,529 Medicare beneficiaries, totaling 2,248 services with total Medicare billing of $144,272. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Barstow, CA
- Active Since 05/15/2013
- Last Updated 11/09/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255777421
Products in Payments
- FARXIGA (Drug) $467.99
- Ozempic (Drug) $194.23
- JARDIANCE (Drug) $119.78
- UBRELVY (Drug) $114.06
- XARELTO (Drug) $95.02
- PRADAXA (Drug) $86.51
- TRULICITY (Drug) $83.19
- KEVEYIS (Drug) $78.51
- Victoza (Drug) $62.75
- Rybelsus (Drug) $55.16
- TRELEGY ELLIPTA (Drug) $52.49
- SPIRIVA RESPIMAT (Drug) $49.75
- PREVNAR 13 (Biological) $48.77
- ENTRESTO (Drug) $45.65
- Dayvigo (Drug) $42.97
- JANUVIA (Drug) $41.48
- ELIQUIS (Drug) $41.24
- EUCRISA (Drug) $36.34
- Enbrel (Biological) $33.10
- AREXVY (Drug) $32.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Barstow
Dr. Kevin Smith, M.d, M.D
Family Medicine — Payments: $3,013
Family Medicine $3,013
Dr. Hemanshu Patel, M.d, M.D
Family Medicine — Payments: $2,614
Family Medicine $2,614
Jessica Basa, M.d, M.D
Family Medicine — Payments: $569.37
Family Medicine $569.37
Leila Joseph, Do, DO
Family Medicine — Payments: $434.56
Family Medicine $434.56
Dr. Kenneth Terry, Do, DO
Family Medicine — Payments: $200.40
Family Medicine $200.40
Mikel Alwis, M.d, M.D
Family Medicine — Payments: $91.02
Family Medicine $91.02